Park Ha Biological Technology Co., Ltd. announced a best-efforts follow-on public offering pricing on January 27, 2026, with 21,875,000 units at $0.112 each, closing on January 28, 2026, and raising about $2.45 million before expenses. The funds will be used to expand directly operated stores in China.